The annual J.P. Morgan Healthcare Conference kicks off on Jan. 7, 2019 in San Francisco and healthcare investors are waiting with bated breath to hear from the executives leading the world's most powerful drug and biotech companies.
More than 450 companies will be presenting, including Celgene (NASDAQ: CELG), Gilead Sciences (NASDAQ: GILD), and Teladoc (NYSE: TDOC) to more than 9,000 attendees. The Motley Fool's healthcare team will keep you informed about the most important announcements and offer our expert analysis. Check back daily for updates!
P.S. If you're interested in checking out how much things have changed since this time in 2018, here's last year's landing page.
10 stocks we like better than CelgeneWhen investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has quadrupled the market.*
David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and Celgene wasn't one of them! That's right -- they think these 10 stocks are even better buys.
Click here to learn about these picks!
*Stock Advisor returns as of November 14, 2018
The Motley Fool owns shares of and recommends Celgene, Gilead Sciences, and Teladoc Health. The Motley Fool has a disclosure policy.